Wendy B. Young insider trades: Rapport Therapeutics (RAPP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Wendy reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | RAPP | ↑ Buy | 3,789 | $26.39 | $100K | Direct | Oct 22, 2026 (0d) |
| Sep 11, 2025 | RAPP | ↑ Buy | 3,500 | $22.60 | $79K | Direct | Sep 11, 2025 (0d) |
| Mar 12, 2025 | RAPP | ↑ Buy | 6,000 | $10.21 | $61K | Direct | Mar 13, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RAPP insiders
Open-market trades in the last 12 months
About Wendy B. Young's insider trades
Wendy B. Young is an insider at Rapport Therapeutics (RAPP). Since Mar 12, 2025, Wendy has reported 3 open-market purchases worth $240K and no sales on SEC Form 4. In the last 12 months: 1 buy ($100K).
Their filings also include grants and awards (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RAPP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.